Centogene N.V. (CNTG)
NASDAQ: CNTG · IEX Real-Time Price · USD
0.489
+0.009 (1.88%)
At close: Apr 26, 2024, 4:00 PM
0.490
+0.001 (0.22%)
After-hours: Apr 26, 2024, 4:17 PM EDT
Centogene Revenue
Centogene had revenue of $55.72M in the twelve months ending June 30, 2023, with 16.11% growth year-over-year. In the year 2022, Centogene had annual revenue of $50.50M with 5.23% growth.
Revenue (ttm)
$55.72M
Revenue Growth
+16.11%
P/S Ratio
0.24
Revenue / Employee
$125,502
Employees
444
Market Cap
13.62M USD
Revenue Chart
* The company reports in EUR currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 50.50M | 2.51M | 5.23% |
Dec 31, 2021 | 47.99M | 1.10M | 2.34% |
Dec 31, 2020 | 46.89M | -7.92M | -14.44% |
Dec 31, 2019 | 54.81M | 8.28M | 17.80% |
Dec 31, 2018 | 46.53M | 8.50M | 22.35% |
Dec 31, 2017 | 38.03M | 8.91M | 30.60% |
Dec 31, 2016 | 29.12M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Trinity Biotech | 56.83M |
Ontrak | 12.74M |
NEXGEL | 4.09M |
Senti Biosciences | 2.56M |
OneMedNet | 1.02M |
CNTG News
- 25 days ago - CENTOGENE Receives Nasdaq Non-Compliance Notice - GlobeNewsWire
- 5 weeks ago - CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders - GlobeNewsWire
- 2 months ago - CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency - GlobeNewsWire
- 2 months ago - CENTOGENE Explores Strategic Alternatives - GlobeNewsWire
- 2 months ago - CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing - GlobeNewsWire
- 3 months ago - CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration - GlobeNewsWire
- 3 months ago - CENTOGENE Receives French Research Tax Credit Accreditation - GlobeNewsWire
- 3 months ago - CENTOGENE Announces Preliminary Full Year 2023 Revenue - GlobeNewsWire